Doctor launches campaign for crowdfunding Rs 1 crore for mother's cancer treatment

On December 8, doctors recommended a four-cycle treatment to Daya that involves a drug named Sacituzumab Govitecan, sold under the brand name Trodelvy.

She was told that this was the last resort to save her life. The drug is not available in India and has to be imported from the US. The total cost of the drug is roughly around $30,000 (Rs 23 lakh) for one cycle of immune-mediated chemotherapy and the entire treatment will cost Rs 1 crore.

With the support of crowdfunding website Impact Guru, Dr Anjali has raised roughly Rs 23.69 lakh in the past 29 days. She still needs over Rs 76 lakh to proceed with the prescribed treatment.

Dr Anjali Gupta told reporters, "I cannot see my mother die. I have served during both the waves of Covid-19 and will do my best to serve society after completing my postgraduation. I request the government and people to help us as my family cannot afford to buy the expensive drug, which is crucial for the treatment of my mother".

Dr Anjali is a junior resident doctor (a final year postgraduation student) at the ophthalmology department of S.N. Medical College. Her father owns a chemist shop in Pratapura. Her brother is a website designer in Punjab.

Also Read: Ensure funds for treatment of kids with rare diseases: Delhi HC directs Centre